These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24387105)

  • 1. Selective ALDH3A1 inhibition by benzimidazole analogues increase mafosfamide sensitivity in cancer cells.
    Parajuli B; Fishel ML; Hurley TD
    J Med Chem; 2014 Jan; 57(2):449-61. PubMed ID: 24387105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of selective inhibitors for human aldehyde dehydrogenase 3A1 (ALDH3A1) for the enhancement of cyclophosphamide cytotoxicity.
    Parajuli B; Georgiadis TM; Fishel ML; Hurley TD
    Chembiochem; 2014 Mar; 15(5):701-12. PubMed ID: 24677340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of aldehyde dehydrogenases of the 1A subfamily as putative anticancer agents: Kinetic characterization and effect on human cancer cells.
    Jiménez R; Pequerul R; Amor A; Lorenzo J; Metwally K; Avilés FX; Parés X; Farrés J
    Chem Biol Interact; 2019 Jun; 306():123-130. PubMed ID: 30958995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldehyde dehydrogenases and cell proliferation.
    Muzio G; Maggiora M; Paiuzzi E; Oraldi M; Canuto RA
    Free Radic Biol Med; 2012 Feb; 52(4):735-46. PubMed ID: 22206977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: a retrospective study. Rational individualization of oxazaphosphorine-based cancer chemotherapeutic regimens.
    Sládek NE; Kollander R; Sreerama L; Kiang DT
    Cancer Chemother Pharmacol; 2002 Apr; 49(4):309-21. PubMed ID: 11914911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of aldehyde dehydrogenases in murine tumor and hematopoietic progenitor cells to inhibition by chloral hydrate as determined by the ability of chloral hydrate to potentiate the cytotoxic action of mafosfamide.
    Maki PA; Sladek NE
    Biochem Pharmacol; 1993 Jan; 45(1):231-9. PubMed ID: 8424816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective protection by stably transfected human ALDH3A1 (but not human ALDH1A1) against toxicity of aliphatic aldehydes in V79 cells.
    Townsend AJ; Leone-Kabler S; Haynes RL; Wu Y; Szweda L; Bunting KD
    Chem Biol Interact; 2001 Jan; 130-132(1-3):261-73. PubMed ID: 11306050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of aldehyde dehydrogenase inhibitors on the ex vivo sensitivity of murine late spleen colony-forming cells (day-12 CFU-S) and hematopoietic repopulating cells to mafosfamide (ASTA Z 7557).
    Kohn FR; Sladek NE
    Biochem Pharmacol; 1987 Sep; 36(17):2805-11. PubMed ID: 2820422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of the cytotoxic action of mafosfamide by N-isopropyl-p-formylbenzamide, a metabolite of procarbazine.
    Maki PA; Sladek NE
    Cancer Res; 1991 Aug; 51(16):4170-5. PubMed ID: 1868438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scaffold hopping based designing of selective ALDH1A1 inhibitors to overcome cyclophosphamide resistance: synthesis and biological evaluation.
    Narendra G; Raju B; Verma H; Kumar M; Jain SK; Tung GK; Thakur S; Kaur R; Kaur S; Sapra B; Silakari O
    RSC Med Chem; 2024 Jan; 15(1):309-321. PubMed ID: 38283216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine hepatic aldehyde dehydrogenase 1a1 is a major contributor to oxidation of aldehydes formed by lipid peroxidation.
    Makia NL; Bojang P; Falkner KC; Conklin DJ; Prough RA
    Chem Biol Interact; 2011 May; 191(1-3):278-87. PubMed ID: 21256123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of aldophosphamide by human aldehyde dehydrogenase isozyme 3.
    Giorgianni F; Bridson PK; Sorrentino BP; Pohl J; Blakley RL
    Biochem Pharmacol; 2000 Aug; 60(3):325-38. PubMed ID: 10856427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human class 3 aldehyde dehydrogenase, and sensitization of tumor cells that express significant amounts of this enzyme to oxazaphosphorines, by chlorpropamide analogues.
    Rekha GK; Devaraj VR; Sreerama L; Lee MJ; Nagasawa HT; Sladek NE
    Biochem Pharmacol; 1998 Feb; 55(4):465-74. PubMed ID: 9514081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human breast adenocarcinoma MCF-7/0 cells electroporated with cytosolic class 3 aldehyde dehydrogenases obtained from tumor cells and a normal tissue exhibit differential sensitivity to mafosfamide.
    Sreerama L; Sladek NE
    Drug Metab Dispos; 1995 Oct; 23(10):1080-4. PubMed ID: 8654195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis characterization and biological evaluation of novel multi-isoform ALDH inhibitors as potential anticancer agents.
    Dinavahi SS; Gowda R; Bazewicz CG; Battu MB; Lin JM; Chitren RJ; Pandey MK; Amin S; Robertson GP; Gowda K
    Eur J Med Chem; 2020 Feb; 187():111962. PubMed ID: 31887569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of selective inhibitors for aldehyde dehydrogenases based on substituted indole-2,3-diones.
    Kimble-Hill AC; Parajuli B; Chen CH; Mochly-Rosen D; Hurley TD
    J Med Chem; 2014 Feb; 57(3):714-22. PubMed ID: 24444054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNAi-mediated knockdown of aldehyde dehydrogenase class-1A1 and class-3A1 is specific and reveals that each contributes equally to the resistance against 4-hydroperoxycyclophosphamide.
    Moreb JS; Mohuczy D; Ostmark B; Zucali JR
    Cancer Chemother Pharmacol; 2007 Jan; 59(1):127-36. PubMed ID: 16614850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3D-QSAR and scaffold hopping based designing of benzo[d]ox-azol-2(3H)-one and 2-oxazolo[4,5-b]pyridin-2(3H)-one derivatives as selective aldehyde dehydrogenase 1A1 inhibitors: Synthesis and biological evaluation.
    Verma H; Narendra G; Raju B; Kumar M; Jain SK; Tung GK; Singh PK; Silakari O
    Arch Pharm (Weinheim); 2022 Sep; 355(9):e2200108. PubMed ID: 35618489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of aldehyde dehydrogenase inhibitors on the ex vivo sensitivity of human multipotent and committed hematopoietic progenitor cells and malignant blood cells to oxazaphosphorines.
    Kohn FR; Landkamer GJ; Manthey CL; Ramsay NK; Sladek NE
    Cancer Res; 1987 Jun; 47(12):3180-5. PubMed ID: 3034402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary breast tumor levels of suspected molecular determinants of cellular sensitivity to cyclophosphamide, ifosfamide, and certain other anticancer agents as predictors of paired metastatic tumor levels of these determinants. Rational individualization of cancer chemotherapeutic regimens.
    Sreerama L; Sládek NE
    Cancer Chemother Pharmacol; 2001 Mar; 47(3):255-62. PubMed ID: 11320670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.